BIOMARKER:

Inflammatory gene signature

Inflammatory gene signature Inflammatory gene signature	Non Small Cell Lung Cancer NSCLC	Inflammatory gene signature Inflammatory gene signature	Non Small Cell Lung Cancer NSCLC	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials
Inflammatory gene signature Inflammatory gene signature	Non Small Cell Lung Cancer NSCLC	Inflammatory gene signature Inflammatory gene signature	Non Small Cell Lung Cancer NSCLC	nivolumab Sensitive: C3 – Early Trials	nivolumab Sensitive: C3 – Early Trials

Associations